Related Experiment Video
Updated: Feb 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Optimal cholesterol levels in patients in real-life. A systematic review]
C Escobar1, V Barrios2, L Pérez de Isla3
1Servicio de Cardiología, Hospital Universitario La Paz, Madrid, España.
Insights
Lowering LDL cholesterol is crucial for preventing atherosclerosis. Current guidelines offer safe targets, but greater reductions may provide additional cardiovascular benefits without increased side effects.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Dyslipidemia is a primary risk factor for atherosclerosis.
- Lowering low-density lipoprotein (LDL) cholesterol is associated with improved cardiovascular outcomes.
- Current clinical practice guidelines provide LDL cholesterol targets that are considered beneficial and safe.
Purpose of the Study:
- To review the evidence supporting LDL cholesterol targets in managing dyslipidemia.
- To discuss the potential benefits of achieving LDL cholesterol levels below guideline recommendations.
- To highlight the challenges in current dyslipidemia management and available therapeutic options.
Main Methods:
- Literature review of studies on dyslipidemia and atherosclerosis.
- Analysis of clinical practice guidelines for lipid management.
- Evaluation of therapeutic strategies for LDL cholesterol reduction.
Main Results:
- Current LDL cholesterol targets are safe and effective.
- Higher reductions in LDL cholesterol may offer additional cardiovascular benefits.
- Despite available treatments like statins, dyslipidemia control remains suboptimal in many patients.
Conclusions:
- Achieving guideline-recommended LDL cholesterol targets is important for cardiovascular health.
- Further reductions in LDL cholesterol may be beneficial for select patient populations.
- Optimizing therapeutic strategies is essential to improve dyslipidemia control and reduce atherosclerotic risk.
Abstract:
Dyslipidaemia is one of the main risk factors for the development of atherosclerosis. Different studies have demonstrated that the lower the LDL cholesterol, the better. Current evidence shows that the LDL cholesterol targets recommended by the clinical practice guidelines are beneficial and safe. However, consistent data show that higher reductions might provide additional cardiovascular beneficial effects, without an increase in side effects. Unfortunately, the current control of dyslipidaemia is very poor. Although statins are the treatment of choice in the majority of patients with dyslipidaemia, the current therapeutic armamentarium has different alternatives that effectively reduce LDL cholesterol levels, and that alone, or in combination, help to achieve LDL cholesterol targets in the majority of patients.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

